PPAR-gamma drugs for Type 2 Diabetes

3 tracked PPAR-gamma drugs in the Type 2 Diabetes race. The class explanation lives on the PPAR-gamma page; the full indication pipeline across every mechanism is on the Type 2 Diabetes page.

1 approved / phase 42 Phase 3

Head-to-head evidence: Lobeglitazone vs Pioglitazone · Lobeglitazone vs Pioglitazone (JT-001) · Pioglitazone vs Pioglitazone (JT-001)

The roster

← all PPAR-gamma drugs